Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

0A4J

Astrazeneca (0A4J)

Astrazeneca Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:0A4J
日付受信時刻ニュースソース見出しコード企業名
2024/01/0300 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/12/2716 : 00UK RegulatoryAstraZeneca PLC AstraZeneca acquires GracellLSE:0A4JAstrazeneca Plc
2023/12/2216 : 00UK RegulatoryAstraZeneca PLC Wainua (eplontersen) granted first US FDA approvalLSE:0A4JAstrazeneca Plc
2023/12/1500 : 00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
2023/12/1216 : 05UK RegulatoryAstraZeneca PLC AstraZeneca to acquire IcosavaxLSE:0A4JAstrazeneca Plc
2023/12/0200 : 05UK RegulatoryAstraZeneca PLC Block listing Interim ReviewLSE:0A4JAstrazeneca Plc
2023/12/0200 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/12/0116 : 00UK RegulatoryAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trialsLSE:0A4JAstrazeneca Plc
2023/11/2400 : 00UK RegulatoryAstraZeneca PLC Director/PDMR ShareholdingLSE:0A4JAstrazeneca Plc
2023/11/1716 : 00UK RegulatoryAstraZeneca PLC Truqap approved in US for HR+ breast cancerLSE:0A4JAstrazeneca Plc
2023/11/1416 : 05UK RegulatoryAstraZeneca PLC Update on PACIFIC-2 Phase III trial for ImfinziLSE:0A4JAstrazeneca Plc
2023/11/1000 : 00UK RegulatoryAstraZeneca PLC Director DeclarationLSE:0A4JAstrazeneca Plc
2023/11/0916 : 10UK RegulatoryAstraZeneca PLC Imfinzi combination improves PFS in liver cancerLSE:0A4JAstrazeneca Plc
2023/11/0916 : 05UK RegulatoryAstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RALSE:0A4JAstrazeneca Plc
2023/11/0916 : 00UK RegulatoryAstraZeneca PLC 9M and Q3 2023 resultsLSE:0A4JAstrazeneca Plc
2023/11/0200 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/11/0116 : 00UK RegulatoryAstraZeneca PLC AstraZeneca cell & gene therapy deal w/ CellectisLSE:0A4JAstrazeneca Plc
2023/10/0315 : 00UK RegulatoryAstraZeneca PLC AstraZeneca settles Nexium liability litigationsLSE:0A4JAstrazeneca Plc
2023/10/0223 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/09/2215 : 00UK RegulatoryAstraZeneca PLC Dato-DXd improved PFS in breast cancerLSE:0A4JAstrazeneca Plc
2023/09/2015 : 00UK RegulatoryAstraZeneca PLC Alexion completes Pfizer gene therapy agreementLSE:0A4JAstrazeneca Plc
2023/09/1523 : 00UK RegulatoryAstraZeneca PLC Enhertu recommended in EU for HER2-mutant NSCLCLSE:0A4JAstrazeneca Plc
2023/09/1200 : 00UK RegulatoryAstraZeneca PLC Fasenra Phase III EGPA trial met primary endpointLSE:0A4JAstrazeneca Plc
2023/09/0615 : 00UK RegulatoryAstraZeneca PLC Update on US review of Ultomiris for NMOSDLSE:0A4JAstrazeneca Plc
2023/09/0123 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/08/0123 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
2023/07/2815 : 05UK RegulatoryAstraZeneca PLC Alexion enters gene therapy agreement with PfizerLSE:0A4JAstrazeneca Plc
2023/07/2815 : 00UK RegulatoryAstraZeneca PLC Half-year ReportLSE:0A4JAstrazeneca Plc
2023/07/1802 : 10UK RegulatoryAstraZeneca PLC Beyfortus approved in US for infant RSV preventionLSE:0A4JAstrazeneca Plc
2023/07/0323 : 00UK RegulatoryAstraZeneca PLC Total Voting RightsLSE:0A4JAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:0A4J

最近閲覧した銘柄

Delayed Upgrade Clock